Foghorn Therapeutics Inc (FHTX)
R&D Expenses
$79.73M
TTM · Period ending: · USD
FHTX R&D Expenses
Latest reported$79.73Mperiod ending
Latest reported$79.73Mperiod ending
FHTX TTM R&D Expenses ($44.36M → $79.73M)
TTM R&D Expenses
High-resolution chart · PNG
FHTX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 79,730,000 | |
| 82,099,000 | |
| 85,466,000 | |
| 83,028,000 | |
| 87,715,000 | |
| 90,620,000 | |
| 94,528,000 | |
| 97,373,000 | |
| 98,935,000 | |
| 104,386,000 | |
| 108,837,000 | |
| 113,692,000 | |
| 114,369,000 | |
| 111,095,000 | |
| 105,618,000 | |
| 99,873,000 | |
| 93,439,000 | |
| 86,107,000 | |
| 80,325,000 | |
| 73,770,000 | |
| 69,389,000 | |
| 64,375,000 | |
| 57,152,000 | |
| 54,764,000 | |
| 49,943,000 | |
| 46,090,000 | |
| 44,362,000 | |
| 36,148,250 | |
| 30,162,500 |